PATENT CLAIM ANALYSIS

Application Number: 15571475
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["514", "330000"]

Abstract:
Provided herein, inter alia, are methods and compounds for inhibiting K-Ras and for treating cancer.

Claim (Index 83):
The compound of  claim 78 , or a pharmaceutically acceptable salt thereof, wherein:\n R 17  is hydrogen, C 1 -C 8  alkyl unsubstituted or substituted with R 78 , C 3 -C 8  cycloalkyl unsubstituted or substituted with R 78 , 3 to 8 membered heterocycloalkyl unsubstituted or substituted with R 78 , C 6 -C 10  aryl unsubstituted or substituted with R 78 , or membered heteroaryl unsubstituted or substituted with R 78 ; each R 78  is independently oxo, halogen, \u2014CN, \u2014OH, \u2014NH 2 , \u2014COOH, \u2014CONH 2 , \u2014NO 2 , \u2014SH, \u2014SO 3 H, \u2014SO 4 H, \u2014SO 2 NH 2 , \u2014NHC(O)\u2014OH, \u2014OCX 78 3 , \u2014OCHX 78 2 , alkyl unsubstituted or substituted with R 79 , cycloalkyl unsubstituted or substituted with R 79 , heterocycloalkyl unsubstituted or substituted with R 79 ; R 79  is independently oxo, halogen, \u2014CN, \u2014OH, \u2014NH 2 , \u2014OCX 79 3 , \u2014OCHX 79 2 , \u2014OCH 2 X 79 , unsubstituted alkyl; and X 78  and X 79  are independently halogen.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 93.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15382942', '15950953', '15757238', '15662861', '15700040']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8587078588130217
- 35 USC 102 Novelty (BERT): 0.5984115502743605
- Combined Prediction Score: 0.8326782279591556
- Mean Citation Score: 535.581868
- Max Citation Score: 593.351
- Similarity Product: 437.8702475602031

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test